Independent Leading Corporate Governance Research

Metrical Inc

METRICAL INC. is an independent leading Corporate Governance research firm in Japan where Corporate Governance is increasingly recognized as an important element on corporate management in these days. Thus, CG research and solutions would become an essential component of global capital markets and play important to contribute to transparency of the markets and maximize shareholders’ value in Japan. 

METRICAL INC. provides Corporate Governance research and analysis including rating services, and  also offers investment research and IR services with solutions and customized profound research on CG and IR issues.

Japan's Governance: Article on the Composition of the Board of Directors of JTEKT Corporation (6473)

Japan's Governance: About the Article on the March Shareholders' Meeting Companies Update

Japan's Governance: About the Article on Outside Directors (2)

Japan's Governance: About the Article on Monex Group (8698)

Japan's Governance: Articles About Torii Pharmaceutical's Annual General Meeting of Shareholders

Japan's Governance: About the Article on Activist

Japan's Governance: About the Articles on Record-High Total Dividends Paid

Executive Director, Metrical Inc

Aki Matsumoto

Executive Director

<ul>
<li>Torii Pharmaceutical rejected a shareholder proposal at its AGM to prohibit "revolving door" appointments of people from JT to the board of directors and to disclose the cost of capital.</li>
<li>The Company disclosed the propriety of opposing these shareholder proposals, but this was not understood to be a sufficient explanation.</li>
<li>Will the Company eventually terminate its parent-subsidiary listing if it does not meet the prime market listing criteria for governance?</li>
</ul>


Torii Pharmaceutical rejected a shareholder proposal at its AGM to prohibit "revolving door" appointments of people from JT to the board of directors and to disclose the cost of capital.
The Company disclosed the propriety of opposing these shareholder proposals, but this was not understood to be a sufficient explanation.
Will the Company eventually terminate its parent-subsidiary listing if it does not meet the prime market listing criteria for governance?


Japan's Governance: Articles About Torii Pharmaceutical's AGM (2)